Trimethadione
Anti-epileptic Agent — NERVOUS SYSTEM
Also known as: tridione, trimetadione, trimetin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Trimethadione is an ofm drug in the Anti-epileptic Agent class catalogued in DrugCentral. It was first approved by the FDA in 1946. DrugCentral lists 1 molecular target, including CACNA1G. Recorded indications include Absence seizure and Epilepsy.
- Approval status: ofm (first approved 1946 by the FDA).
- Drug class: Anti-epileptic Agent.
- Molecular targets: CACNA1G (1 listed in DrugCentral).
- Indications: Absence seizure and Epilepsy.
- ATC code: N03AC02 (Oxazolidine derivatives).
- Molecular formula: C6H9NO3; molecular weight 143.14 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Absence seizure
- Epilepsy
Contraindications (15)
- Acute nephropathy
- Disease of liver
- Disorder of optic nerve
- Eaton-Lambert syndrome
- Hepatic failure
- Kidney disease
- Leukopenia
- Lupus erythematosus and erythema multiforme-like syndrome
- Lymphadenopathy
- Neutropenic disorder
- Porphyria
- Pregnancy, function
- Proteinuria
- Retinal disorder
- Thrombocytopenic disorder
Mechanism & targets
| Established pharmacologic class | Anti-epileptic Agent |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Voltage-dependent T-type calcium channel subunit alpha-1G | CACNA1G | blocker | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1946-01-25 | FDA | — | ABBVIE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N03AC02 | NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Oxazolidine derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Trimethadione is on its molecule page.
| Molecular formula | C6H9NO3 |
|---|---|
| Molecular weight | 143.14 g/mol |
| CAS number | 127-48-0 |
| InChIKey | IRYJRGCIQBGHIV-UHFFFAOYSA-N |
| PubChem CID | 5576 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Trimethadione used for?
DrugCentral lists the following indications for Trimethadione: Absence seizure and Epilepsy.
How does Trimethadione work?
Its molecular targets in DrugCentral include CACNA1G (blocker).
When was Trimethadione first approved?
Trimethadione was first approved by the FDA in 1946.
What drug class does Trimethadione belong to?
Trimethadione is in the Anti-epileptic Agent class.
What is the chemical formula of Trimethadione?
Trimethadione has the molecular formula C6H9NO3 and a molecular weight of 143.14 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2751 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL695 — compound record and bioactivity
- PubChem CID 5576 — chemical identifiers
- DrugBank DB00347 — drug record
- FDA UNII R7GV3H6FQ4 — substance identity
- DailyMed: FDA labels for Trimethadione — current prescribing information (label search)
- UniProt O43497 (CACNA1G) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.